Book Value per Share: Invivyd Corp (IVVD)

Invivyd, Inc. (IVVD) develops monoclonal antibodies to combat viruses, utilizing an R&D model with high margin potential driven by patent leverage. The business relies on its proprietary AI system, which accelerates the modification of molecules to address new strains. The price indicator on the chart, with a value of 0.61, complements the profile of a scientifically recognized innovator rapidly addressing global healthcare challenges.

Invivyd Corp (IVVD): Share Book Value from 04/28/2023 to 10/26/2026

Invivyd Inc - analytical breakdowns and key metrics (IVVD)

- price and consensus price forecast:

Stock Quotes Invivyd Corp|IVVD - Price Target Chart

- market capitalization data:

Market Capitalization Invivyd|IVVD - Business Value

- book capitalization data:

Net Assets per Single Share Invivyd, Inc.|IVVD - Net Asset Value|Market Capitalization to Book Value Ratio invivyd.com|IVVD - Aggregate Asset Value

- debt and liquidity data:

Total Debt to Capital Invivyd, Inc.|IVVD - Long-Term Debt to Capital|Short-Term Debt to Equity Invivyd Corp|IVVD - Aggregate Debt Obligations|Debt to Book Capitalization Ratio Invivyd

Fundamental company valuation:invivyd.com - IVVD

The risk of asset impairment for Invivyd, Inc. (IVVD) is assessed via net equity value, where the trend in book value per share reflects the remaining funds after all liabilities are settled. Investments in robotic bio-screening and AI modeling define this foundation: an increase in this metric confirms effective capitalization of technologies, while a decrease signals a critical cash burn on antibody development.

Competitors of Invivyd, Inc. (IVVD)

GILD - Accounting Value per Share|CDTX - Net Assets per Single Share|Book Value per Share Novavax, Inc.|CVAC (curevac.com) - Equity per Share|Net Assets per Single Share Valneva VALN|Share Book Value Vir Biotechnology Inc|SIGA Corp (SIGA) - Book Value per Share|Accounting Value of a Share Emergent Bio (EBS)|Book Value per Share AVIR (Atea Pharmaceuticals)|enanta.com - Book Value per Share|Net Assets per Single Share Inovio (INO)|HLVX: Accounting Value of a Share|KLRS (Kalaris Therapeutics, Inc.) - Net Assets per Single Share|Dyadic International, Inc. (DYAI) - Accounting Value per Share|NNVC (NanoViricides Inc.) - Book Value per Share|Book Value per Share talphera.com (TLPH)|Cocrystal Pharma (COCP) - Accounting Value per Share|Accounting Value of a Share trawspharma.com TRAW|Accounting Value per Share Dogwood Therapeutics DWTX|Net Assets per Single Share Qualigen Corp QLGN|Book Value per Share ALVR (AlloVir Bio)|VBIV: Net Assets per Share|Net Assets per Single Share virios.com VIRI|Accounting Value of a Share Vaxart